Navigation Links
Gen-Probe Reports Financial Results for the Fourth Quarter of 2011
Date:2/14/2012

les

$155,162$131,093$562,588$522,709Collaborative research revenue

1,3693,7087,68214,518Royalty and license revenue

1,6441,8935,9646,100Total revenues

158,175136,694576,234543,327Operating expenses:Cost of product sales (excluding acquisition-related intangible amortization)

51,74240,104173,645169,222Acquisition-related intangible amortization

2,7602,23111,0618,847Research and development

28,20226,885112,742111,103Marketing and sales

17,05615,01668,39659,492General and administrative

16,24015,61071,39456,818Goodwill and asset impairment charges

12,746—12,746—Total operating expenses

128,74699,846449,984405,482Income from operations

29,42936,848126,250137,845Other income (expense):Investment and interest income

1,3171,4018,69511,765Interest expense

(546)(535)(2,070)(2,216)Gain on contingent consideration

—399—7,994Other-than-temporary impairment loss on equity investment

——(39,482)—Other income (expense), net

(364)(95)(236)(177)Total other income (expense), net

4071,170(33,093)17,366Income before income tax

29,83638,01893,157155,211Income tax expense

9,97710,78043,03348,274Net income

$  19,859$  27,238$  50,124$106,937Net income per share:Basic

$  0.43$  0.57$  1.06$  2.20Diluted

$  0.42$  0.56$  1.04$  2.18Weighted average shares outstanding:Basic

46,11747,82747,25448,560Diluted

46,94448,45548,38749,033Gen-Probe IncorporatedConsolidated Statements of Income – Non-GAAP Reconciliations(In thousands, except per share data)

(Unaudited)Three Months EndedThree Months EndedDecember 31, 2011December 31, 2010Non-GAAPAdjustmentsGAAPNon-GAAPAdjustmentsGAAPRevenues:Product sales

$155,162

$  —

$155,162$131,093

$  —

$131,093Collaborative resea
'/>"/>

SOURCE Gen-Probe Incorporated
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15

Related biology technology :

1. Gen-Probe Reports Financial Results for the Second Quarter of 2011
2. Gen-Probe to Webcast Two Upcoming Investor Presentations
3. Gen-Probe Announces Webcast of First Quarter 2011 Earnings Conference Call
4. Gen-Probe Reports Financial Results for the Fourth Quarter and Full Year 2010
5. Gen-Probe Announces Webcast of Fourth Quarter and Full Year 2010 Earnings Conference Call
6. Gen-Probe to Webcast Presentation at the 29th Annual J.P. Morgan Healthcare Conference
7. Gen-Probe Acquires GTI Diagnostics for $53 Million in Cash
8. Gen-Probe Announces Webcast of Annual Briefing for Institutional Investors and Financial Analysts
9. Gen-Probe to Acquire Prodesse, Leader in Molecular Testing for Respiratory Infectious Diseases, for $60 Million in Cash Plus Potential Milestone Payments
10. Gen-Probe to Consolidate Industrial Assets Into New, Independent Company
11. Gen-Probe to Webcast Four Upcoming Investor Presentations
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/31/2014)... , July 31, 2014 ... Market Research "Quantum Dots Market - Global Industry Analysis, ... the market was valued at USD 88.5 million in ... by 2023, growing at a CAGR of 53.8% from ... Dots Market Report at  http://www.transparencymarketresearch.com/quantum-dots.html Increasing ...
(Date:7/31/2014)... New York, NY (PRWEB) July 31, 2014 ... of New York City, partnered with GI Energy, one of ... to complete a $13 million upgrade of its 43-year-old CHP ... in 1971 and in an effort to extend the life ... of six generators and associated electrical and heat recovery equipment, ...
(Date:7/31/2014)... CollabRx, Inc. (NASDAQ: CLRX), a leading provider ... today announced that it will hold an investor conference ... financial results for the first quarter of fiscal 2015 ... the current fiscal year. , The dial-in number for ... 2014, at 5 p.m. EDT (2 p.m. PDT) is ...
(Date:7/31/2014)... SHENZHEN, China , July 31, 2014 /PRNewswire/ ... of an Irys™System by BGI , ... to enable comprehensive exploration of human structural variation (SV) ... of interest, including those where no reference exists. In ... new methods for multiplexing on the Irys System, enabling ...
Breaking Biology Technology:Global Quantum Dots Market is Expected to Reach USD 8,246.8 Million in 2023: Transparency Market Research 2Global Quantum Dots Market is Expected to Reach USD 8,246.8 Million in 2023: Transparency Market Research 3Global Quantum Dots Market is Expected to Reach USD 8,246.8 Million in 2023: Transparency Market Research 4North Shore Towers Partners with GI Energy to Install Turnkey Natural Gas-Fired Combined Heat and Power Plant 2CollabRx, Inc. Schedules First Quarter Fiscal Year 2015 Financial Conference Call and Business Update 2BioNano Genomics Announces the Purchase of the Irys System by BGI 2BioNano Genomics Announces the Purchase of the Irys System by BGI 3BioNano Genomics Announces the Purchase of the Irys System by BGI 4
... TOKYO, Oct. 22 /Xinhua-PRNewswire/ -- Olympus Capital Holdings ... reached an agreement to,sell Arysta LifeScience Corporation, the ... for an enterprise value of,approximately JPY 250 billion ... for Olympus Capital, a leading middle market private,equity ...
... 21 Boston,Scientific Corporation (NYSE: BSX ) ... patients from its TAXUS ARRIVE 1 and 2 ... Express2(TM) Paclitaxel-Eluting,Coronary Stent System in "real-world" practice. The ... events and repeat,revascularization through two years in complex ...
... be Webcast as Part of AACR Virtual Meeting -, ... RGDX ) today announced that Kathleen Danenberg, the ... on the role,of pharmacogenomics in tailoring medicine at the ... will be held October 22-26, 2007 at the Moscone ...
Cached Biology Technology:Olympus Capital Announces Agreement to Sell Arysta LifeScience Corporation 2Olympus Capital Announces Agreement to Sell Arysta LifeScience Corporation 3ARRIVE Registry Analysis Demonstrates Continued Safety and Efficacy of TAXUS(R) Stent in Complex Real-World Patients 2ARRIVE Registry Analysis Demonstrates Continued Safety and Efficacy of TAXUS(R) Stent in Complex Real-World Patients 3ARRIVE Registry Analysis Demonstrates Continued Safety and Efficacy of TAXUS(R) Stent in Complex Real-World Patients 4Response Genetics' CEO to Discuss Advances in Optimizing Therapy through Pharmacogenomics as Part of a Series of Presentations at AACR-NCI-EORTC International Conference 2Response Genetics' CEO to Discuss Advances in Optimizing Therapy through Pharmacogenomics as Part of a Series of Presentations at AACR-NCI-EORTC International Conference 3
(Date:8/1/2014)... The Journal of Nutrition Education and Behavior (JNEB) announces ... (GEM) awards, which were presented at the Society for ... Impact: Local to Global," in Milwaukee, Wisconsin, June 28 ... the authors of the best article and best GEM ... of the JNEB Journal Committee and Board of Editors. ...
(Date:8/1/2014)... of a new study, including two Simon Fraser ... industry representatives and policymakers must collaborate closely on ... gas development. Viorel Popescu and Maureen Ryan, David ... Sciences department, are among eight international co-authors of ... Ecology and the Environment . , Shale gas ...
(Date:7/31/2014)... tracing nearly 3,000 genes to the earliest common ... scientists have created an extensive "Tree of Lepidoptera" ... DNA sequencing. , Among the study,s more ... small moths than to large ones, which completely ... study also found that some insects once classified ...
Breaking Biology News(10 mins):Scientists warn time to stop drilling in the dark 2Scientists warn time to stop drilling in the dark 3UF study advances 'DNA revolution,' tells butterflies' evolutionary history 2UF study advances 'DNA revolution,' tells butterflies' evolutionary history 3
... international research team co-led by a scientist at Fred ... behind the third most common form of muscular dystrophy. ... represent the latest in the team,s series of groundbreaking ... facioscapulohumeral muscular dystrophy, or FSHD., The team, co-led by ...
... geneticists sheds new light on how Facioscapulohumeral Muscular Dystrophy ... commonly known as FSHD, the devastating disease affects both ... inherited genetic disorder, yet sometimes appears spontaneously via new ... condition. "People with the condition experience progressive ...
... 2012 - Jackson Hole, Wyoming Scientists believe that ... primary genetic material, early,forms of life used RNA to ... life,rely on before RNA? The answer may be ... a hypothetical,backbone for Peptide Nucleic Acids, which have been ...
Cached Biology News:Researchers discover 2 genetic flaws behind common form of inherited muscular dystrophy 2Mutations in genes that modify DNA packaging result in Facioscapulohumeral Muscular Dystrophy 2Mutations in genes that modify DNA packaging result in Facioscapulohumeral Muscular Dystrophy 3Weber State Scientists discover possible building blocks of ancient genetic systems 2
...
MOUSE ANTI HUMAN MOC31:AZIDE FREE...
... utility and flexibility press-to-seal silicone isolators can ... the researcher. They are available either pre-cut ... material that can be easily trimmed to ... and non-cytotoxic and can be used to ...
... the mycobacteria found in Complete Freund's Adjuvant so ... Freund's Adjuvant is used for ... to produce water-in-oil emulsions of immunogens. ... antibody responses which can be attributed to the ...
Biology Products: